States Tighten Medicaid ABA Oversight

Medicaid administrators, including states and insurers or managed care plans, are intensifying scrutiny of autism therapy, especially applied behavior analysis (ABA), as spending increases and concerns grow around billing and care quality. Axios reports that Medicaid spending on autism therapy reportedly quadrupled over five years. The increase has been accompanied by proliferating fraudulent billing and questions about the quality of care being delivered, prompting payers to tighten oversight and, in some cases, payment policies.

Spending Growth and Utilization Controls

The Axios report describes ABA as an intensive, individualized therapy that is typically aimed at young children. It also points to structural factors that can contribute to higher costs and inconsistent practice patterns. In particular, the report argues that a lack of broadly accepted clinical guidelines, combined with fee-for-service incentives, can create openings for overbilling and high-volume care patterns.

In response, states and Medicaid managed care insurers are implementing cost controls that range from payment caps or steep rate reductions to dropping certain providers from networks. Axios notes these moves can create significant instability for families relying on services.

Private Equity Expansion Draws Attention

Axios identifies the growth of private equity ownership in autism therapy as a major accelerant. Brown University publicized research finding that private equity firms acquired more than 500 autism therapy centers over the past decade. Nearly 80% of those acquisitions occurred within a four-year span. The researchers identified 574 private equity–owned centers across 42 states as of 2024. They explicitly flagged potential downstream effects on state Medicaid budgets.

What This Signals for IDD-Adjacent Benefits

The developments are framed as a “signal event” for how Medicaid may respond when an IDD-adjacent benefit category scales quickly without harmonized clinical standards. The Axios report suggests stakeholders should expect tighter utilization management, more credential verification, and a shift away from open-ended fee-for-service reimbursement toward capped, episode-based, or flat-rate models. This shift is positioned as especially likely in waiver-like benefit structures where states face budget pressure and political scrutiny.

For providers, the report indicates payers may request more defensible documentation tied to medical necessity, treatment intensity, staffing ratios, and credential alignment, particularly in markets where the “growth playbook” resembles what researchers describe as private equity scale strategies.